Dana-Farber Cancer Institute shared a post on LinkedIn:
“Our physician scientists presented more than 50 research studies at the 48th annual San Antonio Breast Cancer Symposium earlier this month.
Presentations include new research around improving quality of life for young women with breast cancer, new targeted therapies for metastatic breast cancer, the use of liquid biopsies to predict exceptional response to HER2 directed therapies, and encouraging results from a clinical for older adults with breast cancer.
Additionally, Nolan Priedigkeit, MD, PhD, was the recipient of the 2025 SABCS Rising Star Award and Sara Tolaney, MD, MPH, Chief of the Division of Breast Oncology, was the recipient of the 2025 American Association for Cancer Research Outstanding Investigator Award for Breast Cancer Research.
Learn more about our findings shared at SABCS25 and explore our Newsroom for the latest research updates.”
More posts about SABCS25.
